The Supreme Court in its order dated April 30 observed that the central government could consider using its powers under Sections 92, 100 or 102 of the Patents Act to increase production of essential drugs to meet demand.Centre says exercise of patent waiver provisions for COVID-19 vaccines,drugs #39;counter-productive#39;, prefers diplomacy
The Supreme Court in its order dated April 30 observed that the central government could consider using its powers under Sections 92, 100 or 102 of the Patents Act to increase production of essential drugs to meet demand.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment